Single-use Bioprocessing System Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, France, China, Japan - Size and Forecast 2024-2028

Published: Mar 2024 Pages: 210 SKU: IRTNTR40062

Single-use Bioprocessing System Market Forecast 2024-2028

The global single-use bioprocessing system market size is estimated to grow by USD 15.32 billion, at a CAGR of 19.38% between 2023 and 2028. 

The integration of real-time monitoring and control technology is revolutionizing bioprocessing operations worldwide. By providing enhanced visibility into critical process parameters, these technologies enable data-driven decision-making in real time, resulting in heightened productivity, efficiency, and product quality. Sensors in single-use bioreactors continuously monitor vital metrics like temperature, pH levels, and agitation speed, with data routed to a central control system for analysis and adjustment. This approach facilitates preventive maintenance and troubleshooting through predictive analytics, minimizing downtime and enhancing overall process reliability. As a result, real-time monitoring and control technologies are driving efficiency gains and quality improvements across bioprocessing operations, fueling market growth. 

What will be the Size of the Market During the Forecast Period?

To learn more about this report, Download Report Sample

Segmentation by Application, Product, End-user, and Geography Analysis

The market caters to the growing demand for biologics production, leveraging innovative technologies like HyPerforma single use bioreactors and disposables. These solutions offer advantages in higher use for commercial-scale manufacturing, especially for high-volume pharmaceuticals, in both pre-commercial and commercial-scale settings. With a focus on carbon dioxide (CO2) reduction and flexibility, they are increasingly preferred over traditional fixed stainless steel systems, particularly in single-use facilities operating at clinical scales. Further, biopharmaceutical commercials play a crucial role in shaping the pre-commercial market landscape, influencing stakeholders and generating awareness about upcoming treatments and therapies in the industry.

Application Analysis

The market share by the mAb production segment will be significant during the forecast period. mAb producers are increasingly embracing single-use bioprocessing systems for end-to-end production capabilities, ensuring compliance with GMP and rapid mAb production without compromising quality. Pressure to adopt low-cost technologies for new indications fuels the deployment of single-use purification operations, including filters and bioreactors.

Get a glance at the market contribution of various segments Download PDF Sample

The mAb production segment was valued at USD 1.93 billion in 2018. Further, these systems offer benefits like reduced cross-contamination and preparation time between batches. However, challenges exist in scaling up single-use systems for large-scale production, leading to the use of multiple 2,000 L bioreactors in tandem, as seen in Amgen Inc.'s Singapore facility, driving growth in the mAb segment and the global single-use bioprocessing market.

Product Analysis

Bags and mixers are integral to the formulation and preparation of media, buffers, and viral inactivation processes for biotechnology and pharmaceutical companies. Vendors focus on high-quality raw materials to ensure chemical compatibility. End-users prioritize sterile conditions and regulatory compliance, driving vendors to adhere to GMP standards and ISO certifications. Single-use mixers offer advantages like reduced contamination and downtime compared to stainless steel mixers, with vendors offering customizable options to meet specific production needs. Automation and sensor integration further enhance product offerings, fostering adoption among end-users and driving single-use bioprocessing system market growth.

Bioreactors and fermenters utilize disposable bags and polymeric linings for culturing mammalian cells, offering flexibility and ease of use. Market vendors provide various types of bioreactors, including rocking motion-based and stirred integrated models. Innovative square-shaped bioreactors are gaining popularity for enhanced mixing and simplified cleaning. Compliance with GMP standards drives the launch of new bioreactors, boosting adoption among regulated industries like pharmaceuticals and biotechnology. Single-use fermenters meet the demand for efficient microbial fermentation in producing high-value protein therapeutics, driving market growth.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. North America leads the market, with the US and Canada as key players. The region's pharmaceutical sector drives adoption, aiming for cost reduction and productivity enhancement.

Further, major market players like Danaher Corp., Entegris Inc., Eppendorf SE., and Thermo Fisher Inc. further bolster market availability. Regulatory authorities encourage strategic enhancements in therapeutic approvals, fostering commercial entry of monoclonal antibody-based drugs. This trend will propel the North American market during the forecast period. 

Buy Full Report Now

Key Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

  • 3M Co.: The company offers single use bioprocessing system such as 3M Zeta Plus BC Series Filter Capsule with SP Series Media, 3M LifeASSURE PSN Series Filter Cartridge and 3M LifeASSURE PLA Series Filter Capsule.

ABEC Inc., Adolf Kuhner AG, Advanced Microdevices Pvt. Ltd., Avantor Inc, Celltainer, Compagnie de Saint Gobain, Corning Inc., Danaher Corp., Eppendorf SE, GE Healthcare Technologies Inc., Getinge AB, Meissner Filtration Products Inc., Merck KGaA, Parker Hannifin Corp., PBS Biotech Inc., Sartorius AG, SENTINEL PROCESS SYSTEMS INC., Solaris Biotechnology Srl, Thermo Fisher Scientific Inc., Cytiva, and Entegris Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Dynamics and Customer Landscape

 

The market is witnessing robust growth driven by the rising demand for biopharmaceuticals, including monoclonal antibodies and vaccines, as well as recombinant proteins. Biopharmaceutical companies are increasingly adopting single-use bioprocessing equipment provided by specialized single-use manufacturers. These systems find extensive applications in regenerative medicine, cell and gene therapies, and emerging mRNA and DNA technologies. With advantages such as flexibility, reduced contamination risk, and cost-effectiveness, SUT (Single-use technology) is gaining traction over traditional stainless steel reactors. The market encompasses various offerings like liquid single-use bioprocessing bags and HyPerforma single-use bioreactors tailored for clinical and preclinical as well as pre-commercial and commercial-scale manufacturing in the bioprocessing industry. Our researchers analyzed the market research and growth data with 2023  as the base year, along with the key market growth analysis, trends, and challenges. A holistic analysis of drivers, trends, and challenges will help companies refine their marketing strategies to gain a competitive advantage. 

Key Drivers

Increasing use to minimize the risk of contamination is the key factor driving the market. Some of the major concerns faced by bio manufacturers during production processes are related to the contamination risks involved and the significant expenditure incurred on preventing such risks. Bioprocessing activities are also exposed to various kinds of risks, such as microbial contamination, cross-contamination, and biologic contamination.  Moreover, end-users such as pharmaceutical companies and biotechnology companies operate in a highly regulated market.

Additionally, regulatory authorities such as the US FDA, EMA, and China Food and Drug Administration (CFDA) largely focus on the maintenance of quality and purity standards in the end products as well as in the operational processes by defining stringent guidelines. Thus, the use of pre-sterilized flow paths in every new production batch eliminates the chances of contamination. This helps end-users to establish continuous production batches, thereby increasing productivity, ensuring product integrity and safety, and reducing the time-to-market. Such factors are expected to drive market growth during the forecast period.

Significant Trends

The need for scalability in biopharmaceutical manufacturing is one of the primary market trends shaping the growth. Traditional stainless steel bioprocessing facilities necessitate large initial investments in infrastructure and equipment, as well as ample area for installation and operation. Single-use bioprocessing systems, on the other hand, are a more cost-effective option since they eliminate the need for costly cleaning, validation, and maintenance that comes with reusable equipment. Furthermore, single-use systems require less physical space, allowing for more efficient use of manufacturing facilities and allowing businesses to increase production capacity without extensive facility upgrades.

Furthermore, the implementation of single-use technologies allows biopharmaceutical businesses to streamline their operations, speed time-to-market for new medicines, and respond swiftly to changing market demands, resulting in cost savings and increased industry competitiveness. As a result, the trend toward lower capital expenditures and facility footprints is projected to continue to shape the global biopharmaceutical production landscape. Such factors are expected to drive market growth during the forecast period.

Major Challenges

Issues related to extractable and leachable is the major challenges that affect market growth. Concerns over contamination in single-use bioprocessing systems, stemming from the use of plastics and additives that may interact with drugs and chemicals, are widespread among pharmaceutical and biotechnology companies. Leachables and extractables pose significant risks, potentially impacting product safety and efficacy. Regulatory bodies like the US FDA mandate safety demonstrations for materials used in production systems and drug delivery devices.

Consequently, failure to comply can result in product approval challenges. Despite efforts by market vendors to select safe polymeric materials, ensuring biological compatibility remains a challenge. Testing standards such as USP <661> and USP <87> are crucial, as material failure can lead to significant losses in time and resources. Contamination concerns, particularly from leachables and extractables, pose a significant obstacle to market growth during the forecast period.

Buy Now Full Report

Key Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market growth and forecasting report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

 Customer Landscape

Segment Overview

The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028. 

  • Application Outlook
    • mAb production
    • Vaccine production
    • Plant cell cultivation
    • PSCTs
    • Others
  • Product Outlook
    • Bags and mixers
    • Bioreactors and fermenters
    • Filtration devices and sampling systems
    • Bioprocess containers
    • Others
  • End-user Outlook
    • Pharmaceutical companies
    • CROs and CMOs
    • Biotechnology companies
    • Academic and research institutions
  • Region Outlook
    • North America
      • The U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of World (ROW)
      • Brazil
      • Argentina
      • Australia

Market Analyst Overview:

The market is revolutionizing biomanufacturing with technologically advanced products and solutions from industry leaders like Trelleborg Healthcare. These systems encompass various components such as tubing, connectors, and transfer systems, optimizing workflow in upstream and downstream bioprocessing. With big data analytics, manufacturers enhance efficiency and ensure patient health by addressing chronic illnesses & conditions.

Furthermore, the adoption of disposable technologies and disposable bioreactors is on the rise, catering to the growing demand for commercial biopharmaceutical manufacturing and customized medicine while mitigating risks associated with extractables and leachables. Further, the market is experiencing a surge due to its pivotal role in bioprocesses and clinical trials. With a focus on upstream bioprocessing, these systems offer disposable technology adoption for enhanced efficiency. Key components like apparatus & plants and filtration assemblies streamline operations, providing simple & peripheral elements for work equipment. This sector's growth underscores its importance in modern biopharmaceutical manufacturing and bioprocessing.

Market Scope

Report Coverage

Details

Page number

210

Base year

2023

Historic period

2018-2022

Market forecasting period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 19.38%

Market Growth 2024-2028

USD 15.32 billion

Market structure

Fragmented

YoY growth 2023-2024(%)

17.13

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 37%

Key countries

US, Germany, France, China, and Japan

Competitive landscape

 Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

3M Co., ABEC Inc., Adolf Kuhner AG, Advanced Microdevices Pvt. Ltd., Avantor Inc, Celltainer, Compagnie de Saint Gobain, Corning Inc., Danaher Corp., Eppendorf SE, GE Healthcare Technologies Inc., Getinge AB, Meissner Filtration Products Inc., Merck KGaA, Parker Hannifin Corp., PBS Biotech Inc., Sartorius AG, SENTINEL PROCESS SYSTEMS INC., Solaris Biotechnology Srl, Thermo Fisher Scientific Inc., Cytiva, and Entegris Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download the Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the between 2024 and 2028
  • Precise estimation of the size and its contribution to the market in focus on the parent market
  • Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies' position and classification
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market industry across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 07: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 08: Executive Summary – Chart on Incremental Growth
    • Exhibit 09: Executive Summary – Data Table on Incremental Growth
    • Exhibit 10: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 11: Parent market
    • Exhibit 12: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 13: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 14: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 15: Chart on Global - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 16: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Exhibit 18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global single-use bioprocessing system market 2018 - 2022
      • Exhibit 19: Historic Market Size – Data Table on global single-use bioprocessing system market 2018 - 2022 ($ billion)
    • 4.2 Application Segment Analysis 2018 - 2022
      • Exhibit 20: Historic Market Size – Application Segment 2018 - 2022 ($ billion)
    • 4.3 Product Segment Analysis 2018 - 2022
      • Exhibit 21: Historic Market Size – Product Segment 2018 - 2022 ($ billion)
    • 4.4 End-user Segment Analysis 2018 - 2022
      • Exhibit 22: Historic Market Size – End-user Segment 2018 - 2022 ($ billion)
    • 4.5 Geography Segment Analysis 2018 - 2022
      • Exhibit 23: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)
    • 4.6 Country Segment Analysis 2018 - 2022
      • Exhibit 24: Historic Market Size – Country Segment 2018 - 2022 ($ billion)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 25: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 26: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 27: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 28: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 29: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 30: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 31: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by Application

    • 6.1 Market segments
      • Exhibit 32: Chart on Application - Market share 2023-2028 (%)
      • Exhibit 33: Data Table on Application - Market share 2023-2028 (%)
    • 6.2 Comparison by Application
      • Exhibit 34: Chart on Comparison by Application
      • Exhibit 35: Data Table on Comparison by Application
    • 6.3 mAb production - Market size and forecast 2023-2028
      • Exhibit 36: Chart on mAb production - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 37: Data Table on mAb production - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 38: Chart on mAb production - Year-over-year growth 2023-2028 (%)
      • Exhibit 39: Data Table on mAb production - Year-over-year growth 2023-2028 (%)
    • 6.4 Vaccine production - Market size and forecast 2023-2028
      • Exhibit 40: Chart on Vaccine production - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 41: Data Table on Vaccine production - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 42: Chart on Vaccine production - Year-over-year growth 2023-2028 (%)
      • Exhibit 43: Data Table on Vaccine production - Year-over-year growth 2023-2028 (%)
    • 6.5 Plant cell cultivation - Market size and forecast 2023-2028
      • Exhibit 44: Chart on Plant cell cultivation - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 45: Data Table on Plant cell cultivation - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 46: Chart on Plant cell cultivation - Year-over-year growth 2023-2028 (%)
      • Exhibit 47: Data Table on Plant cell cultivation - Year-over-year growth 2023-2028 (%)
    • 6.6 PSCTs - Market size and forecast 2023-2028
      • Exhibit 48: Chart on PSCTs - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 49: Data Table on PSCTs - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 50: Chart on PSCTs - Year-over-year growth 2023-2028 (%)
      • Exhibit 51: Data Table on PSCTs - Year-over-year growth 2023-2028 (%)
    • 6.7 Others - Market size and forecast 2023-2028
      • Exhibit 52: Chart on Others - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 53: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 54: Chart on Others - Year-over-year growth 2023-2028 (%)
      • Exhibit 55: Data Table on Others - Year-over-year growth 2023-2028 (%)
    • 6.8 Market opportunity by Application
      • Exhibit 56: Market opportunity by Application ($ billion)
      • Exhibit 57: Data Table on Market opportunity by Application ($ billion)

    7 Market Segmentation by Product

    • 7.1 Market segments
      • Exhibit 58: Chart on Product - Market share 2023-2028 (%)
      • Exhibit 59: Data Table on Product - Market share 2023-2028 (%)
    • 7.2 Comparison by Product
      • Exhibit 60: Chart on Comparison by Product
      • Exhibit 61: Data Table on Comparison by Product
    • 7.3 Bags and mixers - Market size and forecast 2023-2028
      • Exhibit 62: Chart on Bags and mixers - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 63: Data Table on Bags and mixers - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 64: Chart on Bags and mixers - Year-over-year growth 2023-2028 (%)
      • Exhibit 65: Data Table on Bags and mixers - Year-over-year growth 2023-2028 (%)
    • 7.4 Bioreactors and fermenters - Market size and forecast 2023-2028
      • Exhibit 66: Chart on Bioreactors and fermenters - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 67: Data Table on Bioreactors and fermenters - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 68: Chart on Bioreactors and fermenters - Year-over-year growth 2023-2028 (%)
      • Exhibit 69: Data Table on Bioreactors and fermenters - Year-over-year growth 2023-2028 (%)
    • 7.5 Filtration devices and sampling systems - Market size and forecast 2023-2028
      • Exhibit 70: Chart on Filtration devices and sampling systems - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 71: Data Table on Filtration devices and sampling systems - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 72: Chart on Filtration devices and sampling systems - Year-over-year growth 2023-2028 (%)
      • Exhibit 73: Data Table on Filtration devices and sampling systems - Year-over-year growth 2023-2028 (%)
    • 7.6 Bioprocess containers - Market size and forecast 2023-2028
      • Exhibit 74: Chart on Bioprocess containers - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 75: Data Table on Bioprocess containers - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 76: Chart on Bioprocess containers - Year-over-year growth 2023-2028 (%)
      • Exhibit 77: Data Table on Bioprocess containers - Year-over-year growth 2023-2028 (%)
    • 7.7 Others - Market size and forecast 2023-2028
      • Exhibit 78: Chart on Others - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 79: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 80: Chart on Others - Year-over-year growth 2023-2028 (%)
      • Exhibit 81: Data Table on Others - Year-over-year growth 2023-2028 (%)
    • 7.8 Market opportunity by Product
      • Exhibit 82: Market opportunity by Product ($ billion)
      • Exhibit 83: Data Table on Market opportunity by Product ($ billion)

    8 Market Segmentation by End-user

    • 8.1 Market segments
      • Exhibit 84: Chart on End-user - Market share 2023-2028 (%)
      • Exhibit 85: Data Table on End-user - Market share 2023-2028 (%)
    • 8.2 Comparison by End-user
      • Exhibit 86: Chart on Comparison by End-user
      • Exhibit 87: Data Table on Comparison by End-user
    • 8.3 Pharmaceutical companies - Market size and forecast 2023-2028
      • Exhibit 88: Chart on Pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 89: Data Table on Pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 90: Chart on Pharmaceutical companies - Year-over-year growth 2023-2028 (%)
      • Exhibit 91: Data Table on Pharmaceutical companies - Year-over-year growth 2023-2028 (%)
    • 8.4 CROs and CMOs - Market size and forecast 2023-2028
      • Exhibit 92: Chart on CROs and CMOs - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 93: Data Table on CROs and CMOs - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 94: Chart on CROs and CMOs - Year-over-year growth 2023-2028 (%)
      • Exhibit 95: Data Table on CROs and CMOs - Year-over-year growth 2023-2028 (%)
    • 8.5 Biotechnology companies - Market size and forecast 2023-2028
      • Exhibit 96: Chart on Biotechnology companies - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 97: Data Table on Biotechnology companies - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 98: Chart on Biotechnology companies - Year-over-year growth 2023-2028 (%)
      • Exhibit 99: Data Table on Biotechnology companies - Year-over-year growth 2023-2028 (%)
    • 8.6 Academic and research institutions - Market size and forecast 2023-2028
      • Exhibit 100: Chart on Academic and research institutions - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 101: Data Table on Academic and research institutions - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 102: Chart on Academic and research institutions - Year-over-year growth 2023-2028 (%)
      • Exhibit 103: Data Table on Academic and research institutions - Year-over-year growth 2023-2028 (%)
    • 8.7 Market opportunity by End-user
      • Exhibit 104: Market opportunity by End-user ($ billion)
      • Exhibit 105: Data Table on Market opportunity by End-user ($ billion)

    9 Customer Landscape

    • 9.1 Customer landscape overview
      • Exhibit 106: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    10 Geographic Landscape

    • 10.1 Geographic segmentation
      • Exhibit 107: Chart on Market share by geography 2023-2028 (%)
      • Exhibit 108: Data Table on Market share by geography 2023-2028 (%)
    • 10.2 Geographic comparison
      • Exhibit 109: Chart on Geographic comparison
      • Exhibit 110: Data Table on Geographic comparison
    • 10.3 North America - Market size and forecast 2023-2028
      • Exhibit 111: Chart on North America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 112: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 113: Chart on North America - Year-over-year growth 2023-2028 (%)
      • Exhibit 114: Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 10.4 Europe - Market size and forecast 2023-2028
      • Exhibit 115: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 116: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 117: Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Exhibit 118: Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 10.5 Asia - Market size and forecast 2023-2028
      • Exhibit 119: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 120: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 121: Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Exhibit 122: Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 10.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Exhibit 123: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 124: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 125: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Exhibit 126: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 10.7 US - Market size and forecast 2023-2028
      • Exhibit 127: Chart on US - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 128: Data Table on US - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 129: Chart on US - Year-over-year growth 2023-2028 (%)
      • Exhibit 130: Data Table on US - Year-over-year growth 2023-2028 (%)
    • 10.8 Germany - Market size and forecast 2023-2028
      • Exhibit 131: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 132: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 133: Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Exhibit 134: Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 10.9 China - Market size and forecast 2023-2028
      • Exhibit 135: Chart on China - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 136: Data Table on China - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 137: Chart on China - Year-over-year growth 2023-2028 (%)
      • Exhibit 138: Data Table on China - Year-over-year growth 2023-2028 (%)
    • 10.10 France - Market size and forecast 2023-2028
      • Exhibit 139: Chart on France - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 140: Data Table on France - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 141: Chart on France - Year-over-year growth 2023-2028 (%)
      • Exhibit 142: Data Table on France - Year-over-year growth 2023-2028 (%)
    • 10.11 Japan - Market size and forecast 2023-2028
      • Exhibit 143: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 144: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 145: Chart on Japan - Year-over-year growth 2023-2028 (%)
      • Exhibit 146: Data Table on Japan - Year-over-year growth 2023-2028 (%)
    • 10.12 Market opportunity by geography
      • Exhibit 147: Market opportunity by geography ($ billion)
      • Exhibit 148: Data Tables on Market opportunity by geography ($ billion)

    11 Drivers, Challenges, and Trends

    • 11.1 Market drivers
      • 11.2 Market challenges
        • 11.3 Impact of drivers and challenges
          • Exhibit 149: Impact of drivers and challenges in 2023 and 2028
        • 11.4 Market trends

          12 Vendor Landscape

          • 12.1 Overview
            • 12.2 Vendor landscape
              • Exhibit 150: Overview on Criticality of inputs and Factors of differentiation
            • 12.3 Landscape disruption
              • Exhibit 151: Overview on factors of disruption
            • 12.4 Industry risks
              • Exhibit 152: Impact of key risks on business

            13 Vendor Analysis

            • 13.1 Vendors covered
              • Exhibit 153: Vendors covered
            • 13.2 Market positioning of vendors
              • Exhibit 154: Matrix on vendor position and classification
            • 13.3 3M Co.
              • Exhibit 155: 3M Co. - Overview
              • Exhibit 156: 3M Co. - Business segments
              • Exhibit 157: 3M Co. - Key news
              • Exhibit 158: 3M Co. - Key offerings
              • Exhibit 159: 3M Co. - Segment focus
            • 13.4 ABEC Inc.
              • Exhibit 160: ABEC Inc. - Overview
              • Exhibit 161: ABEC Inc. - Product / Service
              • Exhibit 162: ABEC Inc. - Key offerings
            • 13.5 Adolf Kuhner AG
              • Exhibit 163: Adolf Kuhner AG - Overview
              • Exhibit 164: Adolf Kuhner AG - Product / Service
              • Exhibit 165: Adolf Kuhner AG - Key offerings
            • 13.6 Advanced Microdevices Pvt. Ltd.
              • Exhibit 166: Advanced Microdevices Pvt. Ltd. - Overview
              • Exhibit 167: Advanced Microdevices Pvt. Ltd. - Product / Service
              • Exhibit 168: Advanced Microdevices Pvt. Ltd. - Key offerings
            • 13.7 Avantor Inc
              • Exhibit 169: Avantor Inc - Overview
              • Exhibit 170: Avantor Inc - Business segments
              • Exhibit 171: Avantor Inc - Key news
              • Exhibit 172: Avantor Inc - Key offerings
              • Exhibit 173: Avantor Inc - Segment focus
            • 13.8 Celltainer
              • Exhibit 174: Celltainer - Overview
              • Exhibit 175: Celltainer - Product / Service
              • Exhibit 176: Celltainer - Key offerings
            • 13.9 Compagnie de Saint Gobain
              • Exhibit 177: Compagnie de Saint Gobain - Overview
              • Exhibit 178: Compagnie de Saint Gobain - Business segments
              • Exhibit 179: Compagnie de Saint Gobain - Key news
              • Exhibit 180: Compagnie de Saint Gobain - Key offerings
              • Exhibit 181: Compagnie de Saint Gobain - Segment focus
            • 13.10 Corning Inc.
              • Exhibit 182: Corning Inc. - Overview
              • Exhibit 183: Corning Inc. - Business segments
              • Exhibit 184: Corning Inc. - Key news
              • Exhibit 185: Corning Inc. - Key offerings
              • Exhibit 186: Corning Inc. - Segment focus
            • 13.11 Danaher Corp.
              • Exhibit 187: Danaher Corp. - Overview
              • Exhibit 188: Danaher Corp. - Business segments
              • Exhibit 189: Danaher Corp. - Key news
              • Exhibit 190: Danaher Corp. - Key offerings
              • Exhibit 191: Danaher Corp. - Segment focus
            • 13.12 Eppendorf SE
              • Exhibit 192: Eppendorf SE - Overview
              • Exhibit 193: Eppendorf SE - Product / Service
              • Exhibit 194: Eppendorf SE - Key offerings
            • 13.13 Getinge AB
              • Exhibit 195: Getinge AB - Overview
              • Exhibit 196: Getinge AB - Business segments
              • Exhibit 197: Getinge AB - Key news
              • Exhibit 198: Getinge AB - Key offerings
              • Exhibit 199: Getinge AB - Segment focus
            • 13.14 Merck KGaA
              • Exhibit 200: Merck KGaA - Overview
              • Exhibit 201: Merck KGaA - Business segments
              • Exhibit 202: Merck KGaA - Key news
              • Exhibit 203: Merck KGaA - Key offerings
              • Exhibit 204: Merck KGaA - Segment focus
            • 13.15 Sartorius AG
              • Exhibit 205: Sartorius AG - Overview
              • Exhibit 206: Sartorius AG - Business segments
              • Exhibit 207: Sartorius AG - Key news
              • Exhibit 208: Sartorius AG - Key offerings
              • Exhibit 209: Sartorius AG - Segment focus
            • 13.16 Solaris Biotechnology Srl
              • Exhibit 210: Solaris Biotechnology Srl - Overview
              • Exhibit 211: Solaris Biotechnology Srl - Product / Service
              • Exhibit 212: Solaris Biotechnology Srl - Key offerings
            • 13.17 Thermo Fisher Scientific Inc.
              • Exhibit 213: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 214: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 215: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 216: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 217: Thermo Fisher Scientific Inc. - Segment focus

            14 Appendix

            • 14.1 Scope of the report
              • 14.2 Inclusions and exclusions checklist
                • Exhibit 218: Inclusions checklist
                • Exhibit 219: Exclusions checklist
              • 14.3 Currency conversion rates for US$
                • Exhibit 220: Currency conversion rates for US$
              • 14.4 Research methodology
                • Exhibit 221: Research methodology
                • Exhibit 222: Validation techniques employed for market sizing
                • Exhibit 223: Information sources
              • 14.5 List of abbreviations
                • Exhibit 224: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              single-use bioprocessing system market market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis